TD Cowen Reiterates Buy Rating on Globe Life with $215 Target
TD Cowen maintains its buy stance on Globe Life, setting a $215 price target as shares trade around $172, a 21.88% upside from the current price.
Key Points
- TD Cowen reiterated its buy rating on Globe Life Inc. (NYSE:GL) with a price target of $215 on June 23, 2026.
- TD Cowen's $215 price target implies 21.88% upside from Globe Life Inc.'s ($GL) current $176.40 share price.
- Globe Life's stock traded near $172.05 on Tuesday, with a market cap of about $13.36 billion and a P/E ratio of 11.91.
- Insider activity included EVP Rebecca Zorn buying 2,000 shares at $98.32 and selling 2,000 shares at $170.10 on June 18, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
TD Cowen has reiterated its buy rating on Globe Life Inc. (NYSE:GL), setting a price target of $215. This update comes as Globe Life shares traded around $172.05 on Tuesday, June 23, 2026.
TD Cowen vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Analysts Set New Price Targets
On June 23, 2026, TD Cowen maintained its buy rating on Globe Life with a $215 price target. The firm's analyst, Andrew Kligerman, continues to hold a positive view of the company. Other analysts, including Piper Sandler and Morgan Stanley, have also maintained their buy ratings with targets of $175 and $181, respectively.
Other Institutional Activity in Globe Life
Several institutional investors have adjusted their positions in Globe Life. BlackRock, Inc. decreased its holdings by 146,546 shares, now holding 5,542,531 shares valued at about $771.35 million, a 2.6% reduction. Vanguard Capital Management LLC opened a new position with 5,149,992 shares worth approximately $716.72 million. State Street Corp increased its stake by 485,155 shares, bringing its total to 3,658,664 shares valued at $509.18 million, marking a 15.3% increase.
Globe Life Inc. Stock Up 2.1%
Shares of Globe Life Inc. (NYSE:GL) traded near $172.05 on Tuesday. The company has a market capitalization of approximately $13.36 billion and a P/E ratio of 11.91. It operates with a beta of 0.499, indicating lower volatility compared to the broader market. The stock's 52-week range spans from $116.73 to $175.63, with a 50-day moving average of $154.99 and a 200-day moving average of $143.00.
$GL price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
In its latest earnings report, Globe Life posted revenue of about $6.07 billion, reflecting a growth rate of 5.4%. The company achieved a net margin of 19.38% and a return on equity of 20.46%. The next earnings release is scheduled for July 22, 2026.
Dividend
Globe Life pays an annual dividend of $1.32 per share, yielding 0.77%. The dividend payout ratio is a conservative 7.89%, indicating room for potential increases.
Insider Buying and Selling at Globe Life Inc.
Recent insider transactions at Globe Life include EVP & Chief Talent Officer Rebecca Zorn buying 2,000 shares at an average price of $98.32 and selling 2,000 shares at $170.10 on June 18, 2026. Additionally, EVP Robert Brian Mitchell and EVP Dolores Skarjune were involved in selling activities earlier in June.
About Globe Life
Globe Life Inc., headquartered in McKinney, Texas, provides life and supplemental health insurance products primarily to lower middle- and middle-income families in the United States. It operates through segments like Life Insurance, Supplemental Health Insurance, and Investments. The company sells its products via direct-to-consumer channels and various agents. Founded in 1900, Globe Life was formerly known as Torchmark Corporation.
Bottom Line
TD Cowen's reiteration of a buy rating and a $215 target for Globe Life underscores the analyst's positive outlook. Investors track such ratings to gauge market sentiment and potential stock performance. As always, it's important to remember that analyst ratings are one of many factors to consider in investment decisions.
Get Globe Life Inc. alerts
New 13F filings, insider trades, and analyst moves on $GL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.